User profiles for Lianne Tile

Lianne Tile

University of Toronto, University Health Network
Verified email at uhn.ca
Cited by 538

[HTML][HTML] Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial

AM Cheung, L Tile, Y Lee, G Tomlinson… - PLoS …, 2008 - journals.plos.org
Background Vitamin K has been widely promoted as a supplement for decreasing bone loss
in postmenopausal women, but the long-term benefits and potential harms are unknown. …

Atypical femur fractures: current understanding and approach to management

L Tile, AM Cheung - Therapeutic Advances in …, 2020 - journals.sagepub.com
Osteoporosis and resulting osteoporotic fractures are responsible for significant morbidity,
excess mortality, and health care costs in the developed world. Medical therapy for …

Garetosmab in fibrodysplasia ossificans progressiva: A randomized, double-blind, placebo-controlled phase 2 trial

…, E Botman, PG Raijmakers, M Al Mukaddam, L Tile… - Nature medicine, 2023 - nature.com
Fibrodysplasia ossificans progressiva (FOP) is a rare disease characterized by heterotopic
ossification (HO) in connective tissues and painful flare-ups. In the phase 2 LUMINA-1 trial, …

Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP. 3 …

AM Cheung, L Tile, S Cardew, S Pruthi… - The lancet …, 2012 - thelancet.com
Background Exemestane can prevent breast cancer in postmenopausal women. Because of
potential widespread use, we examined the safety of exemestane on bone health. Methods …

Garetosmab Reduces flare-ups in patients with fibrodysplasia ossificans progressiva

…, E Botman, MA Mukaddam, L Tile… - Journal of the …, 2021 - academic.oup.com
XLH is the most common heritable rickets. Affected children have high levels of circulating
FGF23 that cause hypophosphatemia with consequent rickets and lower limb deformity. …

Garetosmab, an inhibitor of activin A, reduces heterotopic ossification and flare-ups in adults with fibrodysplasia ossificans progressiva: a randomized, double-blind …

…, E Botman, PG Raijmakers, M Al Mukaddam, L Tile… - medRxiv, 2023 - medrxiv.org
Background Fibrodysplasia ossificans progressiva (FOP), an ultra-rare disorder caused by
mutations in the gene encoding activin A receptor type 1 (ACVR1), is characterized by painful …

Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update

…, IB Rodrigues, L Thabane, CA Thomas, L Tile… - CMAJ, 2023 - Can Med Assoc
Background: In Canada, more than 2 million people live with osteoporosis, a disease that
increases the risk for fractures, which result in excess mortality and morbidity, decreased …

Odanacatib for the treatment of osteoporosis

…, H McDonald-Blumer, R Ridout, L Tile… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Osteoporosis and fragility fractures are important public health concerns.
Cathepsin K inhibitors, including odanacatib , are a novel class of medications for osteoporosis …

Unusual femur stress fractures in children with osteogenesis imperfecta and intramedullary rods on long-term intravenous pamidronate therapy

A Hegazy, M Kenawey, E Sochett, L Tile… - Journal of Pediatric …, 2016 - journals.lww.com
In this report, we describe 6 children with osteogenesis imperfecta with unusual stress
femoral fractures. All children were on long-term cyclic pamidronate treatment. All fractures …

Validation of a calcium assessment tool in postmenopausal Canadian women

A Hung, M Hamidi, E Riazantseva, L Thompson, L Tile… - Maturitas, 2011 - Elsevier
Adequate calcium intake is important for optimal bone health. Assessing dietary calcium
intake, however, is neither widely done nor standardized in North American clinical practices. …